Related Experiment Video
Updated: Dec 2, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study
Jingqi Zhou1, Chang Liu2, Yitang Sun3
1Department of Genetics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA; School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
Insights
Pre-existing Alzheimer's disease and dementia significantly increase COVID-19 hospitalization risk. Genetic variants also show associations with COVID-19, underscoring the need for targeted care for cognitive disorder patients.
Area of Science:
- Medical research
- Genetics
- Epidemiology
Background:
- Understanding COVID-19 risk factors, including pre-existing conditions and genetics, remains incomplete.
- The interplay between clinical history, genetic background, and COVID-19 susceptibility requires further investigation.
Purpose of the Study:
- To identify significant pre-existing medical conditions associated with COVID-19 hospitalization.
- To explore the association between genetic variants in key SARS-CoV-2 related genes (ACE2, TMPRSS2) and COVID-19.
- To examine the link between genetic variations and other phenotypes.
Main Methods:
- Analysis of UK Biobank data from 389,620 participants of European descent.
- Examination of associations between COVID-19 status and 974 medical conditions and 30 blood biomarkers.
- Testing genetic variants in ACE2 and TMPRSS2 genes for association with COVID-19 and other phenotypes.
Main Results:
- Alzheimer's disease (OR=2.29), dementia (OR=2.16), and cognitive disorders (OR=1.90) were identified as significant risk factors for COVID-19 hospitalization.
- Genetic variants (rs7282236) showed association with COVID-19 (OR=1.33) and phenotypes like immune deficiency and prostate cancer.
- Significant p-values were obtained for associations between genetic variants and immune deficiency (p=5.65×10⁻⁵) and prostate cancer (p=1.1×10⁻⁵).
Conclusions:
- Pre-existing Alzheimer's disease and dementia are key risk factors for COVID-19 hospitalization.
- Patients with cognitive disorders require specialized protective measures during the pandemic.
- Evidence supports a direct association between genetic variants and COVID-19 susceptibility.
Introduction:
Our understanding of risk factors for COVID‑19, including pre-existing medical conditions and genetic variations, is limited. To what extent the pre-existing clinical condition and genetic background have implications for COVID-19 still needs to be explored.
Methods:
Our study included 389,620 participants of European descent from the UK Biobank, of whom 3,884 received the COVID-19 test and 1,091 were tested positive for COVID-19. We examined the association of COVID-19 status with an extensive list of 974 medical conditions and 30 blood biomarkers. Additionally, we tested the association of genetic variants in two key genes related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2), with COVID-19 or any other phenotypes.
Results:
The most significant risk factors for COVID-19 include Alzheimer's disease (OR = 2.29, 95% CI: 1.25-4.16), dementia (OR = 2.16, 95% CI: 1.36-3.42), and the overall category of delirium, dementia, amnestic and other cognitive disorders (OR = 1.90, 95% CI: 1.24-2.90). Evidence suggesting associations of genetic variants in SARS-CoV-2 infection-related genes with COVID-19 (rs7282236, OR = 1.33, 95% CI: 1.14-1.54, p = 2.31 × 10-4) and other phenotypes, such as an immune deficiency (p = 5.65 × 10-5) and prostate cancer (p = 1.1 × 10-5), was obtained.
Conclusions:
Our unbiased and extensive search identified pre-existing Alzheimer's disease and dementia as top risk factors for hospital admission due to COVID-19, highlighting the importance of providing special protective care for patients with cognitive disorders during this pandemic. We also obtained evidence suggesting a direct association of genetic variants with COVID-19.
Related Concept Videos
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Psychological and Sociocultural Causes of Schizophrenia
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Positive Symptoms Schizophrenia: Hallucinations and Delusions
Hallucinations
Hallucinations in...

